One simple blood test is all you need –
The LRNAdx Testing Program helps you to detect cancer and monitor treatment without surgery, radition, or biopsies.
One simple blood test is all you need!
Get the most accurate information about your cancer and its molecular features – fast.

Liquid Biopsy Labs' LRNAdx Blood Test is the most thorough and accurate liquid biopsy for cancer detection and monitoring in the world today.
This test has 95% accuracy, even before solid tumours have formed – making it the most accurate test for early cancer detection in the world.
It has been validated across over 20+ different cancers, with more being identified through current studies, making it the most effective early cancer detection and treatment monitoring test across multiple cancers.
It has three distinct uses:
Early Detection of Cancer
Asymptomatic Screening
Treatment Efficacy Monitoring
It is the only exosome-based RNA test in the world.
It tests 20,813 genes: The LRNAdx Test looks at every known gene in the human body. This ensures that every known cancer-related marker and mutation (of which there are over 3,500!) is covered in this single test.








There are currently no other liquid RNA tests in the world.
Liquid Biopsy Labs' LRNAdx Blood Test only tests for active cancer cells – otherwise known as exosomes.
Since we do not waste time testing for dead cells, the results of your LRNAdx Blood Test are solely related to any active cancer in your body.
Every other cancer-related liquid biopsy is using ctDNA.
None of these ctDNA tests – including CDX Liquid; Signaterra; Guardant; and others – can differentiate between dead cells and active cancer cells.
This is why the accuracy rate of those other liquid biopsy tests is so low.
This is also why you have to wait months after treatment and surgeries to use their tests: They can’t differentiate cells that are dead from treatment and cells that are still indicative of active disease.
In this short educational video, you'll see a discussion from one of our live “Office Hours” Zoom calls with cancer specialist, Alex Rolland, and advocacy expert, Michelle Morand.
Alex talks with Karen, a cancer patient and CTOAM client, who shares her experience with advocating for a PET-CT scan and how helpful it has been for her treatment plan.
Importantly, you will hear how certain key pieces of information regarding Karen's diagnosis were completely missed by standard care diagnostics.
Not to mention – her doctor actually told her that getting a PET-CT would not change anything! And that she was wasting her time and money if she still insisted on getting one.
Karen shares what it was like talking to her doctor and being met with resistance...and how she moved forward despite these challenges.
We know that tumours release exosomes which carry the DNA/RNA and proteins the cancer needs to metastasize, and we know that these exosomes can also convert normal cells into tumour cells, so we need to know if they are present ASAP to ensure you get the treatment you need before cancer has a chance to progress.
This test looks to see which of those genes are over-expressed in the exosomes, meaning which genes in your blood are showing up in your blood in higher percentages than they should be when we compare your sample to normal / non-cancerous samples.
With the information this test provides we can zero in on the over-expressed genes that are highly involved in your cancer NOW and identify the level of active cancer in your body, as well as start to point towards the treatments that exist to target the most highly expressed genes.
The LRNAdx Test ensures that patients and doctors have more confidence in which treatment is going to be the most effective; no time wasted and no unnecessary side-effects.
It looks at 20,813 genes found in the exosomes released by tumour cells – all those identified in the widely publicized ‘human genome project’, plus a few thousand genes that have been since identified since.
Given the massive amounts of information and numerous targeted treatment options this testing identifies for each patient, it will not be long before this test is standard-of-care.
In the meantime, we are here to ensure you have the most comprehensive and accurate information from which to make your treatment decisions.
Our team has 60+ combined years in cancer care

About a year after finishing treatment for colorectal cancer, Elena was finally beginning to feel like herself again. Her routine follow-ups had all come back clear, and her doctor reassured her that everything looked good. She was incredibly relieved and back to her usual daily life.
But when a close friend of hers experienced a cancer recurrence, Elena’s peace of mind was shaken.
She started to wonder: Could the same thing happen to me? What if it is, and I just don’t know it?
She brought her concerns to her doctor, but was told additional testing wasn’t needed. The scans and bloodwork showed no signs of trouble.
Still, Elena wanted to be sure. She didn’t like the feeling of concern that kept lingering in the back of her mind each day.
That’s when Elena reached out to our team. We recommended LRNA testing – an advanced molecular test that can detect signals of active cancer at the cellular level (before a tumor even forms!), long before conventional imaging picks it up.
The results were clear: residual cancer activity was still present. Something her routine follow-ups had completely missed.
With this new information, Elena decided to move forward with CTOAM’s Complete Treatment Options Review. Our scientific team used her LRNA results, along with her full medical and genetic profile, to identify the most precise, evidence-based treatment plan available – customized just for her.
We coordinated everything, so she could begin the right targeted therapy immediately. That quick action made all the difference.
Today, Elena is in remission – confident that she made the right choice to go beyond standard care.
Her story is a powerful reminder: even when routine tests say you're fine, molecular insight can reveal the truth – and save lives.

About a year after her second surgery for sarcoma, Rachel was starting to feel like life was getting back to normal. Her mid-2024 scan had come back clear, and her doctors were confident that things were on track.
But during a follow-up CT scan months later, something concerning appeared: new lesions on her shoulder and rib. A bone scan confirmed the spots, but they were dismissed as likely arthritis. She was referred to a neurosurgeon, but after a brief consultation, there was no real follow-up or plan – just a suggestion to watch and wait.
Rachel wasn’t comfortable with that – so she contacted our team.
Because sarcomas are often hard to detect with standard imaging, especially if they’re slow-growing or not PET-avid, we took a different approach. While Michelle pushed for a PET-CT scan, she also arranged an LRNA test – an advanced molecular test designed to detect signs of active cancer at the cellular level, even when scans appear normal.
The results confirmed what imaging hadn’t clearly shown: there was significant cancer activity still present in Rachel’s body.
With this new information in hand, and with the PET-CT now showing clearer signs as well, her doctor referred her to a sarcoma specialist. Within just a few days, she was scheduled for urgent, life-saving surgery to remove a spinal lesion that could have led to paralysis if left untreated.
And the impact of the LRNA test didn’t stop there.
After surgery, our team used Rachel’s molecular profile to develop a personalized, targeted treatment plan, based on the most current scientific evidence – giving her the best possible chance at a full recovery.
Today, Rachel is healing well and continuing treatment tailored to the unique biology of her cancer. She is grateful for the advancements in molecular testing and for listening to her intuition to reach out to our team.
1. Anyone who wants to know if they have active cancer, even before solid tumours have formed.
2. Cancer patients and their doctors who want the most thorough and highly accurate diagnostic test to identify if their treatment is working as it should be – and, if not, when it’s time for a change and what treatments will work better.
3. Patients who are in remission and want to ensure they are still cancer free.

The LRNAdx Blood Test
Including a detailed and easy-to-understand results report and delivery consultation
You receive:
- Onboarding call from our team
- LRNAdx Blood Test
- Test Kit and blood draw
- Phase 1: Preparing the RNA for Next-Generation-Sequencing (performed by our lab team of molecular scientists and genetics specialists)
- Phase 2: NGS process looking at 21,813 genes (performed by our lab team of molecular scientists and genetics specialists)
- Written results report that you can show your doctor
- Delivery consultation
Fee: $2,750.00 CAD + GST
Additional support: Precision Second Opinion
If you would like to optimize the use of your LRNAdx Test results, we offer a Precision Second Opinion.
You receive:
- Collection and organization of your medical records
- Full medical records review
- Personalized research by our team of molecular scientists and genetics specialists
- Complete treatment options review (treatment recommendations proven to be more effective than your current treatment, based on the LRNAdx results of your cancer's molecular features)
Additional fee: $1497.00 + GST
You can add this to your test program and arrange to receive your Precision Second Opinion & Complete Treatment Options Review to coincide with your LRNAdx Test results.

Within four weeks.
From the time we initiate testing to your final LRNAdx Test results report and delivery consultation, the entire process takes approximately four weeks.
Timeline breakdown
- Week 1: Coordination of your blood draw (LRNAdx Test Kit shipment and coordination of blood draw – subject to your availability and location)
- Weeks 2, 3, 4: From the time your sample arrives at our Vancouver NGS Lab, this is the time that is required for our team to process your sample and analyze your results.
- Week 4: Your results report and delivery consult for next steps

For best results, patients should not be on treatment when the blood is drawn; a 2-3 week window is ideal.
This is usually not a concern for most patients, because most standard-of-care protocols provide a 2-3 week break between treatment rounds.
However, if you are not able to have a short treatment break, we can still provide an accurate and thorough result for you if you notify us about the treatment you are on.

What You Can Expect
1. After you complete your intake form, our team will call you
Our team will contact you within 24 business hours (M-F) after you submit your intake form. There is an additional short form for you to fill out further details. We will ensure that any questions you have are answered and that the process is clear.
2. You receive an LRNAdx Test Kit by mail
Our team will arrange for an LRNAdx Test Kit to be shipped to you via mail.
3. A lab tech visits you at home for your blood draw
We will arrange for a laboratory technician to visit you to collect two vials of blood for testing. The laboratory technician will contact you directly to schedule the blood draw appointment at your place of residence.
4. Your blood sample is shipped to our Vancouver lab
Following your blood draw, your sample will be shipped to our next-generation sequencing lab in Vancouver, BC, Canada. This is where the first part of the process happens – including exosome separation and RNA isolation, purification, and conversion to cDNA for sequencing.
5. We analyze your LRNAdx Test results through our NGS technology
Our lab team then uses our state-of-the-art genetic sequencing technology to identify:
a) If active cancer is present in your body – with 95+% certainty – and, if so:
b) To what extent active cancer is present; and which genes are driving your cancer (out of a possible 20,813 genes that the LRNA test looks at).
6. You receive your LRNAdx Test results
Within three weeks of our lab receiving your sample, your results will be presented to you in a detailed and easy-to-understand report from our team.
7. Further support and consultation is available, as needed
If your results indicate cancer activity that you were not aware of, and/or you would like to discuss treatment options based on the molecular features that we have identified through your LRNAdx Test, our team of oncogenomic experts is standing by to help. They can provided you with a Complete Treatment Options Review – please note that additional fees apply for this.

Liquid Biopsy Labs and Cancer Treatment Options and Management have been leaders in the world of precision cancer medicine diagnostics, personalized research, molecular targeted treatment plan design, and cancer care advocacy for over 15 years.
That trend continues with the development of Liquid Biopsy Labs' LRNAdx Test – most thorough and accurate tool for blood-based cancer diagnostics and treatment monitoring, as well as early detection of cancer recurrence, in the world.
Liquid Biopsy Labs is the only company in the world providing this comprehensive, blood-based RNA over-expression testing of tumor-derived exosomes.
We have helped thousands of patients in Canada and around the world have a more beneficial outcome from their cancer care and live longer, healthier lives

STEP 1
Fill Out the Intake Form
You can order the LRNAdx Test directly from CTOAM or Liquid Biopsy Labs.
Just fill out the intake form, and our team will get things started.
You do not need a doctor to order this test.

STEP 2
Your Test Kit is Shipped to You
We will arrange for a test kit to be shipped to you and for a laboratory technician to visit you for the blood draw.
The laboratory technician will contact you directly to schedule the blood draw appointment at your home.

STEP 3
Your Blood Draw Happens
You will be visited by the lab tech at the time of your appointment.
They will follow the instructions on the LRNAdx Test Kit and draw two vials of blood. They will prepare the Test Kit for shipping.

STEP 4
Your Sample is Sent to our Lab
Your sample will be shipped to our next-generation sequencing lab in Vancouver, BC, Canada.
This is where the first part of the process for sequencing happens: exosome separation and RNA isolation, purification, and conversion to cDNA.

STEP 5
We Conduct the Full Test
Our lab team will use our genetic sequencing technology to identify if active cancer is present – with 95+% certainty.
And, if so, to what extent it is present and which genetic mutations (out of a possible 21,813 genes) are driving your cancer.

STEP 6
What Happens After Your Results
You will receive your results in a detailed report, within 3 weeks of our lab receiving your sample.
If your results show active cancer, and/or you would like to discuss treatment options, our team of oncogenomic experts is standing by to help. (Additional fees apply.)





Our team has 60+ combined years in cancer care

Annette F.
Stage 4 survivor, now cancer-free for 8+ years
“We have only good things to say about CTOAM. Alex was just so positive and we enjoyed our phone calls with him because after we talked to him, we were like, okay we can do this! You know, I want the person who knows the most about cancer to be managing my case. And Alex is that person. In 2015 I was diagnosed with stage 4 cancer and I didn't know if I'd be able to see my first daughter graduate highschool. Now it's 8 years later and I was able to do that! And I'm still in long-term remission."

Elke D.
Stage 3 survivor, cancer-free for 4+ years
“I’m thankful to CTOAM for all I’ve learned about cancer and have recommended you to many friends. I had a couple phone consults with Alex two years ago. As a result of his suggestions I asked for a biopsy and genetic analysis and targeted treatment. Fortunately I met the criteria for immunotherapy which has been very effective in treating my lung cancer for the past couple years. My latest scan shows no tumours and I’m off treatment now. I wish I had discovered and trusted CTOAM sooner."

Korey H.
Stage 4 survivor, now living an excellent quality of life for 5+ years
"For a lot of people, I think the route with Alex is sort of a must. I trusted him wholly right away. He shows you the science behind everything and then it’s up to you to decide what you want to do. He goes along with your choices, never forces anything on you. I wished I’d known about CTOAM a lot sooner and talked to you years ago. But thankfully it all worked out. Without Alex, I wouldn't have gotten the immunotherapy and then I'd still be on chemo. Or worse."
Post Address and Mail
Email: admin@ctoam.com
Address
Headquarters:
Suite 377142-757 W. Hastings St. Vancouver BC, V6C 1A1
Get In Touch
Live Assistance Hours
Mon – Fri 8:00am – 5:00pm PT
Toll-free Phone Number:
1-833-493-5463
Phone Number (Canada):
778-999-5463

Office: We serve patients worldwide. Our headquarters is in Vancouver, BC, Canada.
Call 1-833-493-5463
Email: admin@ctoam.com
Site: www.ctoam.com
